Detalhe da pesquisa
1.
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
Ann Surg Oncol
; 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704501
2.
ASO Visual Abstract: Efficacy and Safety of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter, Phase 3 Study.
Ann Surg Oncol
; 2024 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789613
3.
Comparison of patient-reported need of psycho-oncologic support and the doctor's perspective: how do they relate to disease severity in melanoma patients?
Psychooncology
; 25(11): 1271-1277, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26632422
4.
Patterns of care and follow-up care of patients with uveal melanoma in German-speaking countries: a multinational survey of the German Dermatologic Cooperative Oncology Group (DeCOG).
J Cancer Res Clin Oncol
; 147(6): 1763-1771, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33219855
5.
Tumor-reactive CD8+ T-cell responses after vaccination with NY-ESO-1 peptide, CpG 7909 and Montanide ISA-51: association with survival.
Int J Cancer
; 126(4): 909-18, 2010 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19728336
6.
Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells.
J Exp Med
; 195(10): 1279-88, 2002 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12021308
7.
Adjuvant high-dose intravenous immunoglobulins for recalcitrant erosive oral lichen planus: mixed clinical responses.
Eur J Dermatol
; 28(4): 496-501, 2018 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30325320
8.
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Cancer Immun
; 7: 16, 2007 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-17944437
9.
Intratumoral T-cell infiltrates and MHC class I expression in patients with stage IV melanoma.
Cancer Res
; 65(9): 3937-41, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867394
10.
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Clin Cancer Res
; 22(22): 5487-5496, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27185375
11.
[Strip-shaped erythema under polychemotherapy]. / Streifenförmige Erytheme unter Polychemotherapie.
J Dtsch Dermatol Ges
; 8(10): 849-50, 2010 Oct.
Artigo
em Alemão
| MEDLINE | ID: mdl-20883383
12.
HLA-DP4 expression and immunity to NY-ESO-1: correlation and characterization of cytotoxic CD4+ CD25- CD8- T cell clones.
Cancer Immun
; 4: 15, 2004 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-15600300
13.
Efficient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients.
Clin Cancer Res
; 17(4): 861-70, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21163871
14.
Tumor-reactive CD8+ T-cell clones in patients after NY-ESO-1 peptide vaccination.
Int J Cancer
; 121(9): 2042-2048, 2007 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17640060
15.
Identification of new NY-ESO-1 epitopes recognized by CD4+ T cells and presented by HLA-DQ B1 03011.
Int J Cancer
; 118(3): 668-74, 2006 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16152624
16.
Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.
Proc Natl Acad Sci U S A
; 103(39): 14453-8, 2006 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-16984998